STOCK TITAN
  1. Home
  2. Sec-filings
  3. NCNA
  4. [6-K] – NuCana plc (NCNA) (CIK 0001709626)

[6-K] – NuCana plc (NCNA) (CIK 0001709626)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock NCNA logo
Nucana

NASDAQ:NCNA

NCNA Rankings

#6196 Ranked by Market Cap
N/A Ranked by Dividends

NCNA Latest News

Oct 14, 2025
NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy
Sep 5, 2025
NuCana Compliant with All Nasdaq Continued Listing Criteria
Sep 3, 2025
NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025
Aug 20, 2025
NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update
Aug 1, 2025
NuCana Announces ADS Ratio Change

NCNA Latest SEC Filings

Sep 5, 2025
[6-K] NuCana plc American Depositary Share Current Report (Foreign Issuer)
Sep 3, 2025
[6-K] NuCana plc American Depositary Share Current Report (Foreign Issuer)
Aug 20, 2025
[6-K] NuCana plc American Depositary Share Current Report (Foreign Issuer)
Aug 1, 2025
[6-K] NuCana plc American Depositary Share Current Report (Foreign Issuer)
Jul 21, 2025
[6-K] NuCana plc American Depositary Share Current Report (Foreign Issuer)

NCNA Stock Data

11.03M
1.91M
0%
0.24%
18.77%
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
GAITHERSBURG